CABA
Cabaletta Bio Inc
Halal Rating :
Last Price
$2.75
Last updated:
Market Cap
-
7D Change
27.31%
1 Year Change
-86.57%
Company Overview
Industries
Exchange
Next Earnings Date
Cabaletta Bio Inc is a clinical-stage biotechnology company focused on developing engineered T cell therapies for patients with B cell-mediated autoimmune diseases. The company's proprietary technology platform enables the targeting of B cells that produce disease-causing autoantibodies. Their lead product candidate, DSG3-CAART, is being developed for patients with mucosal pemphigus vulgaris (mPV), a rare autoimmune disease.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Cabaletta Bio Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.